103 related articles for article (PubMed ID: 140180)
1. Altered growth hormone and prolactin responses to dopaminergic stimulation in Huntington's chorea.
Caraceni T; Panerai AE; Paratl EA; Cocchi D; Müller EE
J Clin Endocrinol Metab; 1977 May; 44(5):870-5. PubMed ID: 140180
[TBL] [Abstract][Full Text] [Related]
2. Effect of bromoergocriptine on TRH-induced growth hormone and prolactin release in acromegalic patients.
Ishibashi M; Yamaji T; Kosaka K
J Clin Endocrinol Metab; 1977 Aug; 45(2):275-9. PubMed ID: 407240
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous nocturnal plasma prolactin and growth hormone secretion in patients with Parkinson's disease and Huntington's chorea.
Murri L; Iudice A; Muratorio A; Polleri A; Barreca T; Murialdo G
Eur Neurol; 1980; 19(3):198-206. PubMed ID: 6446454
[TBL] [Abstract][Full Text] [Related]
4. Stimulation of prolactin and growth hormone secretion by muscimol, a gamma-aminobutyric acid agonist.
Tamminga CA; Neophytides A; Chase TN; Frohman LA
J Clin Endocrinol Metab; 1978 Dec; 47(6):1348-51. PubMed ID: 162520
[TBL] [Abstract][Full Text] [Related]
5. Growth hormone and prolactin response to bromocriptine in patients with Huntington's chorea.
Chalmers RJ; Johnson RH; Keogh HJ; Nanda RN
J Neurol Neurosurg Psychiatry; 1978 Feb; 41(2):135-9. PubMed ID: 24678
[TBL] [Abstract][Full Text] [Related]
6. Exaggerated growth hormone response to arginine infusion in Huntington's disease.
Leopold NA; Podolsky S
J Clin Endocrinol Metab; 1975 Jul; 41(1):160-3. PubMed ID: 125287
[TBL] [Abstract][Full Text] [Related]
7. Growth hormone hyperresponsiveness to dopaminergic stimulation in Huntington's chorea.
Müller EE; Parati EA; Panerai AE; Cocchi D; Caraceni T
Neuroendocrinology; 1979; 28(5):313-9. PubMed ID: 155781
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of prolactin release by metergoline administration in man.
Delitala G; Masala A; Alagna S; Devilla L; Rovasio PP
Biomedicine; 1977 Jan; 27(1):31-3. PubMed ID: 856312
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of an ergoline derivative, methergoline, on growth hormone and prolactin levels in acromegalic patients.
Chiodini PG; Liuzzi A; Muller EE; Botalla L; Cremascoli G; Oppizzi G; Verde G; Silvestrini F
J Clin Endocrinol Metab; 1976 Aug; 43(2):356-63. PubMed ID: 950367
[TBL] [Abstract][Full Text] [Related]
10. Role of dopamine in the regulation of growth hormone secretion: dopamine and bromocriptine augment growth hormone (GH)-releasing hormone-stimulated GH secretion in normal man.
Vance ML; Kaiser DL; Frohman LA; Rivier J; Vale WW; Thorner MO
J Clin Endocrinol Metab; 1987 Jun; 64(6):1136-41. PubMed ID: 3553220
[TBL] [Abstract][Full Text] [Related]
11. Effect of the dopamine agonist, lergotrile mesylate, on circulating anterior pituitary hormones in man.
Thorner MO; Ryan SM; Wass JA; Jones A; Bouloux P; Williams S; Besser GM
J Clin Endocrinol Metab; 1978 Aug; 47(2):372-8. PubMed ID: 45463
[TBL] [Abstract][Full Text] [Related]
12. Growth hormone (GH) and prolactin responses to repetitive administration of GH-releasing hormone in acromegaly.
Losa M; Schopohl J; König A; Müller OA; von Werder K
J Clin Endocrinol Metab; 1986 Aug; 63(2):475-80. PubMed ID: 3088026
[TBL] [Abstract][Full Text] [Related]
13. Growth hormone and prolactin release in Huntington's chorea.
Chalmers RJ; Johnson RH; Nanda RN
Lancet; 1977 Oct; 2(8042):824. PubMed ID: 71631
[No Abstract] [Full Text] [Related]
14. Effect of dopamine on plasma growth hormone and prolactin levels in normal and acromegalic subjects.
Camanni F; Massara F; Belforte L; Rosatello A; Molinatti GM
J Clin Endocrinol Metab; 1977 Mar; 44(3):465-73. PubMed ID: 838847
[TBL] [Abstract][Full Text] [Related]
15. Plasma growth hormone and prolactin response to dopaminergic GABAmimetic and cholinergic stimulation in Huntington's disease.
Durso R; Tamminga CA; Denaro A; Ruggeri S; Chase TN
Neurology; 1983 Sep; 33(9):1229-32. PubMed ID: 6225034
[TBL] [Abstract][Full Text] [Related]
16. A comparison of the effects of CB-154 and lergotrile mesylate on prolactin and growth hormone secretion in mice.
Sinha YN; Salocks CB; VanderLaan WP
Horm Metab Res; 1976 Sep; 8(5):332-6. PubMed ID: 989755
[TBL] [Abstract][Full Text] [Related]
17. Metabolic studies with bromocriptine in patients with idiopathic parkinsonism and Huntington's chorea.
Kartzinel R; Perlow MD; Carter AC; Chase TN; Calne DB; Shoulson I
Trans Am Neurol Assoc; 1976; 101():53-6. PubMed ID: 141763
[No Abstract] [Full Text] [Related]
18. Induction of growth hormone and prolactin secretion by luteinizing hormone-releasing hormone and its blockade by bromoergocriptine in acromegalic patients.
Ishibashi M; Yamaji T; Kosaka K
J Clin Endocrinol Metab; 1978 Aug; 47(2):418-21. PubMed ID: 400720
[TBL] [Abstract][Full Text] [Related]
19. Plasma growth hormone concentrations in Huntington's chorea.
Phillipson OT; Bird ED
Clin Sci Mol Med; 1976 Jun; 50(6):551-4. PubMed ID: 132332
[TBL] [Abstract][Full Text] [Related]
20. Twenty-four hour plasma levels of growth hormone and prolactin in Huntington's disease.
Durso R; Tamminga CA; Ruggeri S; Denaro A; Kuo S; Chase TN
J Neurol Neurosurg Psychiatry; 1983 Dec; 46(12):1134-7. PubMed ID: 6229607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
